序号 |
标题 |
次数 |
作者 |
发布时间 |
85906 |
DOPE-PEG-DOTA 磷脂-聚乙二醇-大环配体 |
105 |
zyl |
2024-11-22 |
85907 |
N-[4-[1-(2,4-二氨基-6-蝶啶)甲基-3-丁炔基]苯甲酰]-L-谷氨酸烷基酯 |
145 |
WYQ |
2024-11-22 |
85908 |
DOTA-tris(TBE)-amido-dPEG4-TFP ester |
107 |
kx |
2024-11-22 |
85909 |
1,3,5-三[3-(三甲基硅乙炔基)-5-(三异丙基硅乙炔基)苯基乙炔基]苯(B2) |
103 |
WYQ |
2024-11-22 |
85910 |
CAS:177943-88-3 DOTATATE |
100 |
zyl |
2024-11-22 |
85911 |
NOTA-3P-TATE-RGD |
90 |
wyh |
2024-11-22 |
85912 |
1,3,5-三[3-(3-甲基-3-羟基-1-丁炔基)-5-(三异丙基硅乙炔基)苯基乙炔基]苯(B1) |
109 |
WYQ |
2024-11-22 |
85913 |
邻-(3,3-二甲基-1-丁炔基)苯胺 |
87 |
WYQ |
2024-11-22 |
85914 |
p-NH2-Bn-DOTA-tetra(t-Bu ester)的应用领域 |
147 |
kx |
2024-11-22 |
85915 |
8-溴-7-(2-丁炔基)-3,7-二氢-3-甲基-1H-嘌呤-2,6-二酮 |
94 |
WYQ |
2024-11-22 |
85916 |
Tm-Maleimido-DOTA |
108 |
zyl |
2024-11-22 |
85917 |
S,S'-1,4-亚(2-丁炔基)双-L-半胱氨酸(BYDC) |
296 |
WYQ |
2024-11-22 |
85918 |
8-溴-7-(2-丁炔基)-3-甲基黄嘌呤 |
105 |
WYQ |
2024-11-22 |
85919 |
四氮杂环十二烷四乙酸-琥珀酰亚胺酯 |
67 |
zyl |
2024-11-22 |
85920 |
DOTA-Lanreotide |
104 |
kx |
2024-11-22 |
85921 |
DOTA-Leu-Gly-Glu-Tyr-Gly-Phe-Gln-Asn-Ala-Leu-Ile-V |
105 |
wyh |
2024-11-22 |
85922 |
cas:2125661-93-8 DO3A-Serotonin DO3A-血清素 |
120 |
zyl |
2024-11-22 |
85923 |
Lu-DOTA-PP-F11N Lu-DOTA偶联迷你胃泌素类似物PP-F11N |
93 |
zcy |
2024-11-22 |
85924 |
CAS号:909024-55-1,DOTA-cyclo(RGDfK) acetate |
93 |
kx |
2024-11-22 |
85925 |
DOTA-(Tyr3)-Octreotate acetate salt |
94 |
zyl |
2024-11-22 |
85926 |
DOTA-GnRH的基本介绍 |
109 |
wyh |
2024-11-22 |
85927 |
CAS号:1227407-76-2,叠氮基-单-酰胺-DOTA |
99 |
kx |
2024-11-22 |
85928 |
4-羟基-2-丁炔基-2-羟烷基醚 |
119 |
WYQ |
2024-11-22 |
85929 |
DOTA-MSH ;大环配体-MSH多肽 |
93 |
wyh |
2024-11-22 |
85930 |
WSCS-DOTA-BBN功能化的AuNPs WSCS-DOTA-BBN-AuNPs |
119 |
zcy |
2024-11-22 |
85931 |
3-碘-2-丙炔基-丁基氨基甲酸酯 |
108 |
WYQ |
2024-11-22 |
85932 |
CAS号:272120-41-9,DOTA tribenzyl ester |
81 |
kx |
2024-11-22 |
85933 |
DOTA缀合肽M2pep DOTA-M2pep |
137 |
zcy |
2024-11-22 |
85934 |
CAS号:173308-19-5,DOTAMA(t-BuO)3-en |
90 |
kx |
2024-11-22 |
85935 |
3-(3,3,3-三氟-1-丙炔基)-2,2-二甲基环丙烷羧酸酯 |
94 |
WYQ |
2024-11-22 |
85936 |
DOTA-tris(TBE)-amido dPEG-MAL |
98 |
zyl |
2024-11-22 |
85937 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
103 |
kx |
2024-11-22 |
85938 |
DOTA-PEG-biotin DOTA-聚乙二醇-生物素 |
89 |
zcy |
2024-11-22 |
85939 |
DOTA-PEG(23)-bromoacetamide*2TFA |
97 |
zyl |
2024-11-22 |
85940 |
CAS号:219143-29-0,DOTA-(MeAm)4 |
99 |
kx |
2024-11-22 |
85941 |
DOTA(tBu3)-PEG(4)-TFP |
95 |
zyl |
2024-11-22 |
85942 |
DOTA-MBP 齐岳定制 |
108 |
zcy |
2024-11-22 |
85943 |
CAS号:293295-66-6,Y-DOTA-TOC |
86 |
kx |
2024-11-22 |
85944 |
CAS:2792156-83-1 IPB-K(DOTA)-FAPI |
91 |
zyl |
2024-11-22 |
85945 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-Ser-Ser-Ser-LTVSPWY |
107 |
zcy |
2024-11-22 |
85946 |
CAS号:474424-15-2,dota-pnp |
94 |
kx |
2024-11-22 |
85947 |
CU-64 DOTA-TATE |
108 |
zyl |
2024-11-22 |
85948 |
DOTA-hLL2 螯合剂DOTA偶联人源化抗体hLL2 |
108 |
zcy |
2024-11-22 |
85949 |
DOTA-PSMA-EB-01 |
97 |
zyl |
2024-11-22 |
85950 |
1610950-41-8,DOTA-MeTz,DOTA-甲基四嗪 |
94 |
kx |
2024-11-22 |